Strike action between Monday 2 October to Thursday 5 October 2023

Consultants and junior doctors at The Christie will both strike between 7am on Monday 2 October to 7am on Thursday 5 October 2023. Both consultants and junior doctors will still provide emergency care during their strikes.

We are proactively contacting patients with appointments that may be affected by this strike. If you have an appointment at the Trust on any of these dates, please continue to come to The Christie and our other centres as planned unless we contact you to tell you otherwise. There may be longer waits than usual in clinics during this time.

Please do not call to check if your appointment is still going ahead.

Skip to Content

Breast Cancer Study Day

Tuesday 5 October 2021 - via livestream

A virtual education event covering important topics in all areas of the breast pathway to help breast multidisciplinary teams get up-to-date after (or in spite of) the COVID pandemic.


  • Power hour: getting you up to speed at speed! 5 short presentations on important breast updates for 2021/2022
  • Greater depth sessions focusing on:
    • Early diagnosis and screening
    • Research and trials
    • Improving patient pathways
    • Secondary breast cancer
  • Breakout sessions aimed at different roles with the breast MDT

Suitable for all members of the breast multidisciplinary team including doctors, specialist nurses, allied health professionals, and researchers.

Gold sponsor


Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than 3 decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

Silver sponsors

Pierre Fabre

With a portfolio spanning from prescription drugs and consumer healthcare products to dermo-cosmetics, Pierre Fabre is the 2nd largest dermo-cosmetics laboratory in the world and the 2nd largest private French pharmaceutical group. Its portfolio includes several global brands and franchises, such as Pierre Fabre Dermatologie and Pierre Fabre Oncologie.

Pierre Fabre is committed to delivering treatment options to patients with cancer and has been working with oncologists for 30 years to make a difference in their clinical practice.

Pierre Fabre is 86%-owned by the Pierre Fabre Foundation, a government-recognised public-interest foundation.  Pierre Fabre Limited is the UK subsidiary of Pierre Fabre.

Pierre Fabre has funded the educational/scientific content of this meeting only. It has not been involved with or influenced the content, agenda or speaker selection.





Bronze sponsor

Lilly Oncology

Sign up to our education events mailing list to be kept up to date with this and future events

Last updated: July 2023